Uses AI-driven infrared (IR) fingerprinting technology to identify and characterize small molecules, glycans, and metabolites in biological samples within minutes, significantly reducing the time required for molecular analysis. This enables faster biomarker discovery, product characterization, and metabolite structural identification, improving research efficiency and accelerating advancements in healthcare, pharmaceuticals, and agritech.
Funding
$109.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Identifying and characterizing small molecules, glycans, and metabolites in biological samples is a time-consuming process, often taking weeks or months using traditional methods. This slow pace hinders biomarker discovery, product characterization, and metabolite structural identification, delaying advancements in healthcare, pharmaceuticals, and agritech. Existing tools often lack the sensitivity to detect trace amounts or the ability to definitively identify molecular structures.
Solution
Isospec Analytics offers an AI-driven infrared (IR) fingerprinting technology that rapidly identifies and characterizes small molecules in biological samples, reducing analysis time to minutes. The core technology, based on cryogenic infrared ion spectroscopy (CIRIS), generates unique, information-rich metrics that allow for the rapid identification of unknown molecules. By combining analytical chemistry, photonics, and cryogenic materials, Isospec's platform overcomes the limitations of traditional methods, enabling researchers to unlock new biological information and accelerate breakthroughs in diagnostics, therapeutics, and nutrition. The technology facilitates the discovery of new disease biomarkers and supports the development of safer nutritional and pharmaceutical products.
Target Audience
The primary audience includes researchers in pharmaceuticals, nutrition, and agritech companies, as well as clinical researchers and scientists focused on biomarker discovery and molecular analysis.
Features
- AI-enhanced IR fingerprinting technology for rapid molecular identification
- Proprietary CIRIS technology that captures elusive molecular structures
- High sensitivity to detect trace amounts of molecules in biological samples
- Ability to generate data that definitively identifies the structure of a molecule
- Integration of analytical chemistry, photonics, and cryogenic materials
- Applications in biomarker discovery, product characterization, metabolite structural identification, and glycan sequencing
- Technology applicable to the analysis of sugars and metabolites within the food and agritech industry for quality control and product R&D